Arch Therapeutics, Inc.
ARTH
Revenue
30.91k
▼-953.00▼-2.99%
3 Months ChangeAssets
1.40M
▼-142.42k▼-9.25%
3 Months ChangeLiabilities
9.47M
▼-113.35k▼-1.18%
3 Months ChangeFree Cash Flow
-1.13M
▲194.21k▲14.67%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-26
Form 8-K
ID: 0001493152-24-038340
2024-09-19
Form 8-K
ID: 0001493152-24-037130
2024-09-13
Form 8-K
ID: 0001493152-24-036208
2024-08-30
Form 8-K
ID: 0001493152-24-034600
2024-08-20
Form 8-K
ID: 0001493152-24-033295
2024-08-19
Form 10-Q
ID: 0001493152-24-033091
2024-08-16
Form 8-K
ID: 0001493152-24-032876
2024-08-16
Form 8-K
ID: 0001493152-24-032873
2024-08-02
Form 8-K
ID: 0001493152-24-030082
2024-07-22
Form 8-K
ID: 0001493152-24-028684